H.C. Wainwright lowered the firm’s price target on Reviva Pharmaceuticals (RVPH) to $11 from $14 and keeps a Buy rating on the shares. Johnson ...

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Disc Medicine (IRON – Research Report) today and set a price target of $118.00.

H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...

HC Wainwright restated their buy rating on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $18.00 price ...

BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the“Company”), a leader in blockchain infrastructure and technology, has announced its ...

HC Wainwright decreased their Q3 2025 EPS estimates for shares of Applied Digital in a research note issued to investors on ...

Fintel reports that on January 17, 2025, HC Wainwright & Co. downgraded their outlook for CECO Environmental (NasdaqGS:CECO) ...

BigBear.ai Holdings Inc (BBAI) stock saw a modest uptick, ending the day at $4.41 which represents a slight increase of $0.49 or 12.50% from the prior close of $3.92. The stock opened at $3.94 and ...

If you want to stay updated on the latest options trades for SoundHound AI, Benzinga Pro gives you real-time options trades ...

Verve Therapeutics Inc (VERV) stock saw a modest uptick, ending the day at $6.57 which represents a slight increase of $0.43 or 7.00% from the prior close of $6.14. The stock opened at $6.25 and ...

On Friday, H.C. Wainwright reaffirmed its Buy rating and $50.00 price target for Akero Therapeutics (NASDAQ:AKRO), representing significant upside potential from the current trading price of $24.01.

On Thursday, H.C. Wainwright adjusted its price target for Galiano Gold (NYSE:GAU) shares, lowering it to $3.10 from the previous $4.60, while maintaining a Buy rating for the stock. The ...